June 7, 2011

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

June 2, 2011

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

June 1, 2011

The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.

June 1, 2011

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

April 11, 2011

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

January 17, 2011

Japanese drug maker Takeda Pharmaceutical has signed an agreement with Durham, N.C.-based Zinfandel Pharmaceuticals to develop a test for assessing Alzheimer’s disease risk in adults, the two companies said.

January 5, 2011

BOLOGNA, Italy — Data from a new study by scientists in Italy could help physicians calculate patients’ risks for Alzheimer’s disease and heart attacks. Researchers at the University of Bologna said they found a common genetic link between heart attacks and Alzheimer’s, according to results of a study published in the Journal of Alzheimer’s Disease.


November 7, 2010

According to a study published in the November edition of Alzheimer’s & Dementia: The Journal...

November 7, 2010

Eli Lilly's acquisition of a leader in molecular imaging development could boost its Alzheimer's disease...

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

October 3, 2010

Privately owned drug-development company ProteoTech will work with a Chinese company to develop a drug...

September 26, 2010

Nestle will set up a health-and-wellness division to address such problems as obesity, cardiovascular disease,...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 9, 2010

A small study conducted by Canadian researchers found factors that may link Type 2 diabetes...

September 7, 2010

The generics division of Pfizer will sell an authorized generic version of a drug used...

September 6, 2010

Biotech drugs for treating Alzheimer’s disease will more than triple the size of the market...

August 26, 2010

Those with Type 2 diabetes may be at greater risk of developing the brain plaques...

August 16, 2010

Lackluster results have prompted Eli Lilly to stop two late-stage clinical trials of a drug...

July 19, 2010

More than 300 medications for treating mental disorders are in development, according to a new...

July 6, 2010

Sandoz has launched a version of a drug for treating dementia, the generics arm of...

July 5, 2010

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 30, 2010

Watson Pharmaceuticals has launched a generic version of a drug used to treat dementia under...

June 22, 2010

The Food and Drug Administration has approved a drug made by Forest Labs and Germany-based...

May 13, 2010

Drug maker Eisai and the Alzheimer’s Association are calling for nominations for the 2010 C.A.R.E....